The SMART study demonstrated that CD4-guided intermittent ART was inferior to continuous ART for major clinical outcomes.
References and Resources
retroconference.org
Sponsored by The Doctor’s Channel
The SMART study demonstrated that CD4-guided intermittent ART was inferior to continuous ART for major clinical outcomes.
References and Resources
retroconference.org
Sponsored by The Doctor’s Channel